Engineering the perfect (bacterial) cancer therapy
Open accessThe DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in certain cases, injection of intratumoral bacteria or their antigens may conversely provide immunostimulatory effects, as demonstrated by Coley’s toxins and recent developments in bacterial cancer therapy (5, 105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
In the citing paper
“BCT is re-gaining attention through synthetic biology techniques that programmatically limit systemic toxicities while enhancing regional antitumor immunity (105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guzman, L. M., Belin, D., Carson, M. J., & Beckwith, J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4121-4130.1995 · Cited by 4,935
(1989) · PubMed · Cited by 3,343
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · cited 1×
“Many treatments, including chemotherapy and radiation, are toxic to normal tissue and cannot completely destroy all cancer cell”
BackgroundTumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Automated design of synthetic ribosome binding sites to control protein expression
Salis, H. M., Mirsky, E. A., & Voigt, C. A. (2009) · Nature Biotechnology · doi:10.1038/nbt.1568 · Cited by 1,844
CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA
COLEY, W. B. (1891) · Annals of Surgery · doi:10.1097/00000658-189112000-00015 · Cited by 715
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“This containment is one possible reason that attenuated Salmonella had limited success in reducing tumour growth in human trial”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563 · cited 1×
“For propulsion and sensing, bacteria have flagella that enable tissue penetratio”
BackgroundCombinatorial engineering of intergenic regions in operons tunes expression of multiple genes
Pfleger, B. F., Pitera, D. J., Smolke, C. D., & Keasling, J. D. (2006) · Nature Biotechnology · doi:10.1038/nbt1226 · Cited by 536 · cited 1×
“, including gene copy number, promoter strength, optimized codons, bacterial metabolism, mRNA secondary structur”
BackgroundTumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Zhao, M., Yang, M., Li, X.-M., Jiang, P., Baranov, E., Li, S., Xu, M., Penman, S., & Hoffman, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408422102 · Cited by 484
Low, K. B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., et al. (1999) · Nature Biotechnology · doi:10.1038/5205 · Cited by 476
Salmonella: A Model for Bacterial Pathogenesis
Ohl, M. E., & Miller, S. I. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.259 · Cited by 473
Yu, Y. A., Shabahang, S., Timiryasova, T. M., Zhang, Q., Beltz, R., Gentschev, I., Goebel, W., & Szalay, A. A. (2004) · Nature Biotechnology · doi:10.1038/nbt937 · Cited by 423
The next frontier of molecular medicine: Delivery of therapeutics
Jain, R. K. (1998) · Nature Medicine · doi:10.1038/nm0698-655 · Cited by 407 · cited 1×
“Three major causes of these problems are incomplete tumour targeting, inadequate tissue penetration and limited toxicity to all cancer cell”
BackgroundOral Somatic Transgene Vaccination Using Attenuated S. typhimurium
Darji, A., Guzmán, C. A., Gerstel, B., Wachholz, P., Timmis, K. N., Wehland, J., Chakraborty, T., & Weiss, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80465-1 · Cited by 396
Clairmont, C., Lee, K. C., Pike, J., Ittensohn, M., Low, K. B., Pawelek, J., Bermudes, D., Brecher, S. M., Margitich, D., Turnier, J., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315497 · Cited by 355
Nauts, H. C., Swift, W. E., & Coley, B. L. (1946) · PubMed · Cited by 346
Nemunaitis, J., Cunningham, C., Senzer, N., Kuhn, J., Cramm, J., Litz, C., Cavagnolo, R., Cahill, A., Clairmont, C., & Sznol, M. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700634 · Cited by 341 · cited 1×
“This containment is one possible reason that attenuated Salmonella had limited success in reducing tumour growth in human trial”
BackgroundZhao, M., Yang, M., Ma, H., Li, X., Tan, X., Li, S., Yang, Z., & Hoffman, R. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0716 · Cited by 305 · cited 1×
“The importance of this mechanism for promoting accumulation is supported by the increased tumour specificity of auxotrophic Salmonella that require leucine and arganine, which are nutrients derived from dying tumour tissu”
BackgroundStreilein, J. W. (1995) · Science · doi:10.1126/science.270.5239.1158 · Cited by 295
Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization
Sizemore, D. R., Branstrom, A. A., & Sadoff, J. C. (1995) · Science · doi:10.1126/science.270.5234.299 · Cited by 285
Malmgren, R. A., & Flanigan, C. (1955) · PubMed · Cited by 263
Genetic parts to program bacteria
Voigt, C. A. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.09.001 · Cited by 254 · cited 1×
“Rates of protein drug production can be optimized by manipulating multiple factor”
BackgroundKasinskas, R. W., & Forbes, N. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2618 · Cited by 250 · cited 1×
“and chemotactic receptors that direct chemotaxis towards molecular signals in the tumour microenvironmen”
BackgroundSelf-citationZhao, M., Geller, J., Ma, H., Yang, M., Penman, S., & Hoffman, R. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703867104 · Cited by 244
Leschner, S., Westphal, K., Dietrich, N., Viegas, N., Jablonska, J., Lyszkiewicz, M., Lienenklaus, S., Falk, W., Gekara, N., Loessner, H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006692 · Cited by 236
Jiang, S.-N., Phan, T. X., Nam, T.-K., Nguyen, V. H., Kim, H.-S., Bom, H.-S., Choy, H. E., Hong, Y., & Min, J.-J. (2010) · Molecular Therapy · doi:10.1038/mt.2009.295 · Cited by 226
Stritzker, J., Weibel, S., Hill, P. J., Oelschlaeger, T. A., Goebel, W., & Szalay, A. A. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.01.008 · Cited by 224 · cited 1×
“External control can be achieved using gene promoter strategies that respond to small molecule”
BackgroundGenetically Engineered Salmonella typhimurium as an Imageable Therapeutic Probe for Cancer
Nguyen, V. H., Kim, H.-S., Ha, J.-M., Hong, Y., Choy, H. E., & Min, J.-J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3453 · Cited by 214 · cited 1×
“Selective cytotoxicity can be engineered by transfection with genes for therapeutic molecules, including toxin”
BackgroundKim, S. H., Castro, F., Paterson, Y., & Gravekamp, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4855 · Cited by 210
Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro
Kasinskas, R. W., & Forbes, N. S. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20883 · Cited by 209 · cited 1×
“and chemotactic receptors that direct chemotaxis towards molecular signals in the tumour microenvironmen”
BackgroundSelf-citationContainment of Tumor-Colonizing Bacteria by Host Neutrophils
Westphal, K., Leschner, S., Jablonska, J., Loessner, H., & Weiss, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2984 · Cited by 197 · cited 1×
“, bacteria can replicate unimpeded by the macrophage and neutrophil clearance mechanisms that normally serve to eliminate the”
BackgroundLiu, S.-C., Minton, N., Giaccia, A., & Brown, J. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301659 · Cited by 194
Minton, N. P. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro777 · Cited by 192
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors
Ryan, R. M., Green, J., Williams, P. J., Tazzyman, S., Hunt, S., Harmey, J. H., Kehoe, S. C., & Lewis, C. E. (2009) · Gene Therapy · doi:10.1038/gt.2008.188 · Cited by 191
Nishikawa, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28045 · Cited by 183 · cited 1×
“It functions by sensitizing immune cells and preventing the formation of tumours that present those antigen”
BackgroundForbes, N. S., Munn, L. L., Fukumura, D., & Jain, R. K. (2003) · PubMed · Cited by 183
Self-citationAttenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth
Loeffler, M., Le'Negrate, G., Krajewska, M., & Reed, J. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701959104 · Cited by 180
Ganai, S., Arenas, R. B., & Forbes, N. S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605403 · Cited by 179
Self-citationHeimann, D. M., & Rosenberg, S. A. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200303000-00011 · Cited by 177
Thamm, D. H., Kurzman, I. D., King, I., Li, Z., Sznol, M., Dubielzig, R. R., Vail, D. M., & MacEwen, E. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2510 · Cited by 174
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria
Bettegowda, C., Dang, L. H., Abrams, R., Huso, D. L., Dillehay, L., Cheong, I., Agrawal, N., Borzillary, S., McCaffery, J. M., Watson, E. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036598100 · Cited by 172 · cited 1×
“Finally, determining the correct combination of bacteria and other cancer therapie”
BackgroundUse of preferentially replicating bacteria for the treatment of cancer
Sznol, M., Lin, S. L., Bermudes, D., Zheng, L.-M., & King, I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9818 · Cited by 170 · cited 1×
“; and protection from clearance by the immune syste”
BackgroundQuantitative bioluminescence imaging of tumor-targeting bacteria in living animals
Min, J.-J., Nguyen, V. H., Kim, H.-J., Hong, Y., & Choy, H. E. (2008) · Nature Protocols · doi:10.1038/nprot.2008.32 · Cited by 170 · cited 1×
“Bioluminescent bacteria are generated by transformation with plasmids containing the luxCDABE operon from Photobacterium leiognathi”
BackgroundA Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs
Cheong, I., Huang, X., Bettegowda, C., Diaz, L. A., Kinzler, K. W., Zhou, S., & Vogelstein, B. (2006) · Science · doi:10.1126/science.1130651 · Cited by 168 · cited 1×
“Finally, determining the correct combination of bacteria and other cancer therapie”
BackgroundZhang, L., Gao, L., Zhao, L., Guo, B., Ji, K., Tian, Y., Wang, J., Yu, H., Hu, J., Kalvakolanu, D. V., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0098 · Cited by 149 · cited 1×
“Silencing is achieved by transferring plasmids encoding small hairpin RNAs (shRNA) from Salmonella into cancer cell”
BackgroundA Factor of Importance in the Radio Sensitivity of Tumours
Mottram, J. C. (1936) · The British Journal of Radiology · doi:10.1259/0007-1285-9-105-606 · Cited by 146
MOESE, J. R., & MOESE, G. (1964) · PubMed · Cited by 141
Nagakura, C., Hayashi, K., Zhao, M. D., Yamauchi, K., Yamamoto, N., Tsuchiya, H., Tomita, K., Bouvet, M., & Hoffman, R. M. (2009) · PubMed · Cited by 134
IL-18-producing Salmonella inhibit tumor growth
Loeffler, M., Le'Negrate, G., Krajewska, M., & Reed, J. C. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.48 · Cited by 133
Theys, J., Pennington, O., Dubois, L., Anlezark, G., Vaughan, T., Mengesha, A., Landuyt, W., Anné, J., Burke, P. J., Dûrre, P., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603367 · Cited by 132
Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium
Hayashi, K., Zhao, M. D., Yamauchi, K., Yamamoto, N., Tsuchiya, H., Tomita, K., & Hoffman, R. M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22078 · Cited by 132
Visualizing Implanted Tumors in Mice with Magnetic Resonance Imaging Using Magnetotactic Bacteria
Benoit, M. R., Mayer, D., Barak, Y., Chen, I. Y., Hu, W., Cheng, Z., Wang, S. X., Spielman, D. M., Gambhir, S. S., & Matin, A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3206 · Cited by 131
Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth
Loeffler, M. W., Le'Negrate, G., Krajewska, M., & Reed, J. C. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0555-9 · Cited by 121
Antitumor Effect of VNP20009, an Attenuated Salmonella, in Murine Tumor Models
Luo, X., Li, Z., Lin, S., Le, T., Ittensohn, M., Bermudes, D., Runyab, J. D., Shen, S.-Y., Chen, J., King, I. C., et al. (2001) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504001108747512 · Cited by 118
Hayashi, K., Zhao, M. D., Yamauchi, K., Yamamoto, N., Tsuchiya, H., Tomita, K., Kishimoto, H., Bouvet, M., & Hoffman, R. M. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7891 · Cited by 118
Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand
Loeffler, M., Le’Negrate, G., Krajewska, M., & Reed, J. C. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn205 · Cited by 113
Colonisation ofClostridiumin the body is restricted to hypoxic and necrotic areas of tumours
Lambin, P., Theys, J., Landuyt, W., Rijken, P. F. J. W., van der Kogel, A., van der Schueren, E., Hodgkiss, R. J., Fowler, J., Nuyts, S., de Bruijn, E. A., et al. (1998) · Anaerobe · doi:10.1006/anae.1998.0161 · Cited by 112 · cited 1×
“Obligate anaerobes (for example, Clostridium and Bifidobacterium ) cannot survive in oxygen, and injected bacterial spores can only germinate in the anoxic regions of tumour”
BackgroundNuyts, S., van Mellaert, L., Theys, J., Landuyt, W., Bosmans, E., Anné, J., & Lambin, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301499 · Cited by 111
Min, J., Kim, H., Park, J. H., Moon, S., Jeong, J., Hong, Y.-J., Cho, K., Nam, J. H., Kim, N., Park, Y., et al. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0120-5 · Cited by 110 · cited 1×
“Bioluminescent bacteria are generated by transformation with plasmids containing the luxCDABE operon from Photobacterium leiognathi”
BackgroundLoessner, H., Endmann, A., Leschner, S., Westphal, K., Rohde, M., Miloud, T., Hämmerling, G., Neuhaus, K., & Weiss, S. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00890.x · Cited by 109 · cited 1×
“External control can be achieved using gene promoter strategies that respond to small molecule”
BackgroundEffect of Histolyticus Infection and Toxin on Transplantable Mouse Tumors.
Parker, R. C., Plummer, H. C., Siebenmann, C. O., & Chapman, M. G. (1947) · Experimental Biology and Medicine · doi:10.3181/00379727-66-16124 · Cited by 107
Oxygen regulation in Salmonella typhimurium
Strauch, K. L., Lenk, J. B., Gamble, B. L., & Miller, C. G. (1985) · Journal of Bacteriology · doi:10.1128/jb.161.2.673-680.1985 · Cited by 104
Carey, R. W., Holland, J. F., Whang, H. Y., Neter, E., & Bryant, B. (1967) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(67)90060-6 · Cited by 104 · cited 1×
“There was sufficient enthusiasm to initiate a small clinical trial, and oncolysis was observed in three out of five patients following injection with Clostridium butyricum”
BackgroundIn vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit
Royo, J. L., Becker, P. D., Camacho, E. M., Cebolla, Á., Link, C., Santero, E., & Guzmán, C. A. (2007) · Nature Methods · doi:10.1038/nmeth1107 · Cited by 104 · cited 1×
“The salicylate system is also tightly regulated and its cascade amplifies gene expression, producing induction ratios of 20–150-fold in vitro”
Backgroundal-Ramadi, B. K., Fernández-Cabezudo, M. J., Elhasasna, H., Al‐Salam, S., Bashir, G. H., & Chouaı̈b, S. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.08.021 · Cited by 104
Bacteria in gene therapy: bactofection versus alternative gene therapy
Pálffy, R., Gardlík, R., Hodosy, J., Behuliak, M., Resko, P., Radvánský, J., & Celec, P. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302635 · Cited by 103
Lee, C., Wu, C., & Shiau, A. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700777 · Cited by 102
Weibel, S., Stritzker, J., Eck, M., Goebel, W., & Szalay, A. A. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01122.x · Cited by 102
Antitumor effect of Bifidobacterium infantis in mice.
Kohwi, Y., Imai, K., Tamura, Z., & Hashimoto, Y. (1978) · PubMed · Cited by 102
Bacterial therapies: completing the cancer treatment toolbox
Jean, A. S., Zhang, M., & Forbes, N. S. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.08.004 · Cited by 101
Self-citationSaltzman, D. A., Heise, C. P., Hasz, D. E., Zebede, M., Kelly, S. M., Curtiss, R., Leonard, A. S., & Anderson, P. M. (1996) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1996.11.145 · Cited by 100
Targeting Vascular and Avascular Compartments of Tumors with C. novyi-NT and Anti-microtubule Agents
Dang, L. H., Bettegowda, C., Agrawal, N., Cheong, I., Huso, D., Frost, P., Loganzo, F., Greenberger, L., Barkoczy, J., Pettit, G. R., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.3.704 · Cited by 97
Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium
Kimura, H. J., Zhang, L., Zhao, M., Hayashi, K., Tsuchiya, H., Tomita, K., Bouvet, M., Wessels, J. T., & Hoffman, R. M. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00652.x · Cited by 95
Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models
Lee, C., Wu, C., & Shiau, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.626 · Cited by 93 · cited 1×
“These mechanisms enable Salmonella to accumulate in tumours at ratios greater than 1000/1 compared with organs that are rich in reticuloendothelial cells (such as the liver and spleen) and Salmonella accumulate at even greater ratios in other organ”
BackgroundRegression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine.
Pan, Z.-K., Weiskirch, L. M., & Paterson, Y. Y. W. (1999) · PubMed · Cited by 92
Brader, P., Stritzker, J., Riedl, C. C., Zanzonico, P., Cai, S., Burnazi, E. M., Ghani, E. R., Hricak, H., Szalay, A. A., Fong, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4254 · Cited by 91
Friedlos, F., Lehouritis, P., Ogilvie, L., Hedley, D., Davies, L., Bermudes, D., King, I., Martin, J., Marais, R., & Springer, C. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4800 · Cited by 91
The liquefaction (oncolysis) of malignant gliomas by a non pathogenic Clostridium
Heppner, F. L., & M�se, J. R. (1978) · Acta Neurochirurgica · doi:10.1007/bf01406639 · Cited by 90
Mengesha, A., Dubois, L., Lambin, P., Landuyt, W., Chiu, R. K., Wouters, B. G., & Theys, J. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.9.2951 · Cited by 90
Tumor-targeting prodrug-activating bacteria for cancer therapy
Cheng, C.-M., Lu, Y.-L., Chuang, K.-H., Hung, W., Shiea, J., Su, Y.-C., Kao, C.-H., Chen, B.-M., Roffler, S. R., & Cheng, T.-L. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.10 · Cited by 88
Maletzki, C., Linnebacher, M., Kreikemeyer, B., & Emmrich, J. (2008) · Gut · doi:10.1136/gut.2007.125419 · Cited by 87
Antitumor Effects in Mice of the Intravenous Injection of Attenuated Salmonella Typhimurium
Rosenberg, S. A., Spiess, P. J., & Kleiner, D. E. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200205000-00004 · Cited by 87
Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK
Soghomonian, S., Doubrovin, M., Pike, J., Luo, X., Ittensohn, M., Runyan, J. D., Balatoni, J., Finn, R. D., Gelovani, J. G., Blasberg, R. G., et al. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700779 · Cited by 84
Lee, C.-H., Wu, C.-L., Tai, Y.-S., & Shiau, A.-L. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.008 · Cited by 83
ONCOLYSIS BY CLOSTRIDIA. V. TRANSPLANTED TUMORS OF THE HAMSTER.
Engelbart, K., & Gericke, D. (1964) · PubMed · Cited by 81
ONCOLYSIS BY CLOSTRIDIA. III. EFFECTS OF CLOSTRIDIA AND CHEMOTHERAPEUTIC AGENTS ON RODENT TUMORS.
Thiele, E. H., Arison, R. N., & Boxer, G. E. (1964) · PubMed · Cited by 81
Barbé, S., Mellaert, L., Theys, J., Geukens, N., Lammertyn, E., Lambin, P., & Anné, J. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.03.037 · Cited by 79
Salmonella Promoters Preferentially Activated Inside Tumors
Arrach, N., Zhao, M., Porwollik, S., Hoffman, R. M., & McClelland, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0552 · Cited by 78 · cited 1×
“To identify bacterial promoters that could be used in environmental-triggering strategies, Arrach et al”
BackgroundOral cytokine gene therapy against murine tumor using attenuatedSalmonella typhimurium
Yuhua, L., Kunyuan, G., Hui, C., Yongmei, X., Chaoyang, S., Xun, T., & Daming, R. (2001) · International Journal of Cancer · doi:10.1002/ijc.1489 · Cited by 77
Yang, N., Zhu, X., Chen, L., Li, S., & Ren, D. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.1.5195 · Cited by 76 · cited 1×
“Silencing is achieved by transferring plasmids encoding small hairpin RNAs (shRNA) from Salmonella into cancer cell”
BackgroundCarboxypeptidase G2-based gene-directed enzyme–prodrug therapy: a new weapon in the GDEPT armoury
Hedley, D., Ogilvie, L. M., & Springer, C. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2247 · Cited by 73
Fensterle, J., Bergmann, B., Yone, C. L. R. P., Hotz, C., MEYER, S. R., Spreng, S., Goebel, W., Rapp, U. R., & Gentschev, I. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701109 · Cited by 70 · cited 1×
“Because of this early success, this approach persists in many contemporary strategie”
BackgroundTheys, J., Nuyts, S., Landuyt, W., Van Mellaert, L., Dillen, C., Böhringer, M., Dürre, P., Lambin, P., & Anné, J. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.10.4295-4300.1999 · Cited by 70
Nuyts, S., Van Mellaert, L., Theys, J., Landuyt, W., Lambin, P., & Anné, J. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0716:tuorib]2.0.co;2 · Cited by 69
Tjuvajev, J., Blasberg, R. G., Luo, X., Zheng, L., King, I., & Bermudes, D. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00340-6 · Cited by 68
Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium.
Rosenberg, S. A., Spiess, P. J., & Kleiner, D. E. (2002) · PubMed · doi:10.1097/01.cji.0000014623.45316.93 · Cited by 68
Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers
Weiß, S., & Chakraborty, T. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00247-0 · Cited by 68 · cited 1×
“Soon after, it was shown that Salmonella could also be used for trans-kingdom DNA transfe”
BackgroundA Commotion in the Blood: Life, Death, and the Immune System
Hall, S. S. (1997) · Medical Entomology and Zoology · Cited by 67
Tumor Amplified Protein Expression Therapy: Salmonella as a Tumor-Selective Protein Delivery Vector
Zheng, L.-M., Luo, X., Feng, M., Li, Z., Le, T., Ittensohn, M., Trailsmith, M., Bermudes, D., Lin, S. L., & King, I. C. (2001) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504001108747602 · Cited by 66
Antitumour effects of genetically engineered Salmonella in combination with radiation
Platt, J. T., Sodi, S., Kelley, M., Rockwell, S., Bermudes, D. G., Low, K. B., & Pawelek, J. M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00336-1 · Cited by 66
Lee, C., Wu, C., & Shiau, A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23047 · Cited by 66 · cited 1×
“Immunosensitization is one of the key mechanisms of Salmonella cytotoxicity; accumulation of Salmonella choleraesuis in tumours induces neutrophil infiltration and antitumour immune response”
BackgroundTumor-Targeted Salmonella: Highly Selective Delivery Vectors
Bermudes, D. G., Low, B., & Pawelek, J. M. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46817-4_6 · Cited by 66
Attenuated Salmonella typhimurium with IL-2 Gene Reduces Pulmonary Metastases in Murine Osteosarcoma
Sorenson, B. S., Banton, K. L., Frykman, N. L., Leonard, A. S., & Saltzman, D. A. (2008) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-008-0243-2 · Cited by 64
Liu, S.-C., Ahn, G., Kioi, M., Dorie, M.-J., Patterson, A. V., & Brown, J. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1698 · Cited by 64
Saltzman, D. A., Katsanis, E., Heise, C. P., Hasz, D. E., Vigdorovich, V. I., Kelly, S. M., Curtiss, R., Leonard, A. S., & Anderson, P. M. (1997) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(97)90198-6 · Cited by 61
Functional antibodies produced by oncolytic clostridia
Groot, A. J., Mengesha, A., van der Wall, E., van Diest, P. J., Theys, J., & Vooijs, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.126 · Cited by 61 · cited 1×
“For example, Clostridium novyi has been modified to express single-chain antibodies that bind the hypoxia inducible factor 1α (HIF1α) antige”
BackgroundGericke, D., & Engelbart, K. (1964) · PubMed · Cited by 60
Jia, L.-J., Xu, H.-M., Ma, D.-Y., Hu, Q.-G., Huang, X.-F., Jiang, W.-H., Li, S.-F., Jia, K.-Z., Huang, Q.-L., & Hua, Z.-C. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.8.1891 · Cited by 59
Oral delivery of tumor‐targeting Salmonella for cancer therapy in murine tumor models
Jia, L., Wei, D., Sun, Q., Huang, Y., Wu, Q., & Hua, Z. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00503.x · Cited by 59 · cited 1×
“Following oral administration in mice, Salmonella preferentially accumulated in tumours and maintained its anticancer effect”
BackgroundOral delivery of tumor‐targeting Salmonella exhibits promising therapeutic efficacy and low toxicity
Chen, G., Wei, D., Jia, L., Tang, B., Shu, L., Zhang, K., Xu, Y., Gao, J., Huang, X., Jiang, W., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01337.x · Cited by 48
Nuyts, S., Theys, J., Landuyt, W., Mellaert, L. V., Lambin, P., & Anné, J. (2001) · PubMed · Cited by 48
Whole-body imaging of bacterial infection and antibiotic response
Hoffman, R. M., & Zhao, M. D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.376 · Cited by 47
Gentschev, I., Fensterle, J., Schmidt, A., Potapenko, T., Troppmair, J., Goebel, W., & Rapp, U. R. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-15 · Cited by 45
Sorenson, B. S., Banton, K. L., Frykman, N. L., Leonard, A. S., & Saltzman, D. A. (2008) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2008.02.048 · Cited by 44
Fu, W., Lan, H., Li, S., Han, X., Gao, T., & Ren, D. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.19 · Cited by 43
Anti-tumor effects of the bacterium caulobacter crescentus in murine tumor models
Bhatnagar, P. K., Awasthi, A., Nomellini, J. F., Smit, J., & Suresh, M. R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.5.2553 · Cited by 42
Attenuated Bacteria as Effectors in Cancer Immunotherapy
al-Ramadi, B. K., Fernández-Cabezudo, M. J., Elhasasna, H., Al‐Salam, S., Attoub, S., Xu, D., & Chouaïb, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1414.036 · Cited by 40
Lee, S., Kim, S., Jeong, K., Kim, K.-S., Kim, Y.-H., Kim, S., Kim, E., Kim, J.-W., & Chang, K. (2009) · PubMed · doi:10.4014/jmb.0901.505 · Cited by 40
Dresselaers, T., Theys, J., Nuyts, S., Wouters, B. G., de Bruijn, E. A., Anné, J., Lambin, P., Hecke, P. V., & Landuyt, W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601345 · Cited by 38
Zuo, S., Chen, Y., Wu, Z. P., Liu, X., Liu, C., Zhou, Y. C., Wu, C. L., Jin, C. G., Gu, Y. L., Li, J., et al. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.174 · Cited by 38 · cited 1×
“The transfer of genes for two tumour antigens has been shown to be effective at reducing tumour growth in mouse models: α-fetoprotein (AFP) and VEGF receptor 2 (VEGFR2; also known as FLK1”
BackgroundFu, W., Chu, L., Han, X., Liu, X., & Ren, D. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1191 · Cited by 37 · cited 1×
“Using a similar strategy to direct expression, the reduction of tumour growth was shown by transferring the genes encoding TRAIL and SMAC (also known as DIABLO) into tumour cells from Salmonella”
MethodChou, C.-K., Hung, J.-Y., Liu, J.-C., Chen, C.-T., & Hung, M. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700927 · Cited by 34
Fu, W., Lan, H., Liang, S., Gao, T., & Ren, D. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00808.x · Cited by 32
Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimurium.
Mei, S., Theys, J., Landuyt, W., Anné, J., & Lambin, P. (2002) · PubMed · Cited by 32
Attenuated Salmonella typhimurium invades and decreases tumor burden in neuroblastoma
Barnett, S. J., Soto, L. J., Sorenson, B. S., Nelson, B. W., Leonard, A. S., & Saltzman, D. A. (2005) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2005.03.015 · Cited by 31
Insertion or Deletion of the Cheo Box Modifies Radiation Inducibility of Clostridium Promoters
Nuyts, S., Mellaert, L. V., Barbé, S., Lammertyn, E., Theys, J., Landuyt, W., Bosmans, E., Lambin, P., & Anné, J. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.10.4464-4470.2001 · Cited by 27 · cited 1×
“To reduce basal expression and increase radiation responsiveness, Nuyts et al”
BackgroundYoon, W., Choi, W. C., Sin, J., & Park, Y. (2007) · Biotechnology Letters · doi:10.1007/s10529-006-9270-9 · Cited by 27
Feltis, B., Miller, J. S., Sahar, D. E., Kim, A. S., Saltzman, D. A., Leonard, A. S., Wells, C. L., & Sielaff, T. D. (2002) · Journal of Surgical Research · doi:10.1016/s0022-4804(02)96428-0 · Cited by 21
Shilling, D., Smith, M. J. F., Tyther, R., Sheehan, D., England, K., Kavanagh, E. G., Redmond, H. P., Shanahan, F., & O’Mahony, L. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03393.x · Cited by 18
Oncolysis by a new strain of Clostridium.
Möhr, U., Boldingh, W. H., Emminger, A., & Behagel, H. A. (1972) · PubMed · Cited by 15
Dubois, L. J., Dresselaers, T., Landuyt, W., Paesmans, K., Mengesha, A., Wouters, B. G., Hecke, P. V., Theys, J., & Lambin, P. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603624 · Cited by 14
Arakawa, M., Sugiura, K., Hc, R., & Cc, S. (1968) · PubMed · Cited by 13
Li, Y., Chen, H., Kunyuan, G., Yongmei, X., Feng, W., Kuangcheng, X., Jiangsheng, H., & Daming, R. (2001) · Chinese Science Bulletin · doi:10.1007/bf02900689 · Cited by 11
Keke, F., Hongyang, Z., Chen, J., Yao, D., Xiaobing, J., & Zhou, W. (2004) · Current Medical Science · doi:10.1007/bf02861875 · Cited by 10 · cited 1×
“The transfer of genes for two tumour antigens has been shown to be effective at reducing tumour growth in mouse models: α-fetoprotein (AFP) and VEGF receptor 2 (VEGFR2; also known as FLK1”
BackgroundAntitumour activity of Salmonella typhimurium VNP20047 in B16(F10) murine melanoma model.
Jazowiecka-Rakus, J., & Szala, S. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3569 · Cited by 10
Qi, H., Li, Y., & Zheng, S.-B. (2006) · PubMed · Cited by 4
Li, Y., Yuhua, Chen, Hui, Guo, Kunyuan, Xie, Yongmei, Wang, Feng, et al. (2001) · 中国科学通报:英文版 · Cited by 4
ONCOLYTIC EFFECT OF PROTEUS MIRABILIS UPON TUMOR-BEARING ANIMALS
Arakawa, M., Sugiura, K., Reilly, H. C., & Stock, C. (1968) · doi:10.20772/cancersci1959.59.2_117 · Cited by 3
Cited by
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
“Bacteria can bypass problems associated with poor selectivity and limited tumor penetrability of conventional cancer chemotherapies and can be finely engineered to sense and respond to the tumor microenvironment.(392) One strategy is to utilize the native bacterial cytotoxicity to kill cancer cells.”
BackgroundFusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
“the potential utility of bacterial cancer therapy (Forbes 2010), an approach that relies fundamentally on the availability of microbes”
BackgroundLu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“Though historically contentious, BCT is regaining attention through synthetic biology techniques that programmatically limit systemic toxicities while enhancing regional antitumor immunity (105, 106).”
BackgroundTumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Metadata
- Authors
- Forbes, N. S.
- Affiliations
- University of Massachusetts Amherst (US)
- Corresponding author
- Forbes, Neil S.
- ORCID
- Forbes, Neil S.
- Venue
- Nature Reviews Cancer
- Published
- 2010-10-14
- Volume
- 10
- Issue
- 11
- Pages
- 785-794
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3756932
- OpenAlex
- W1979507175
- Cited by
- 905
- References
- 141
- Citations by year
- 2026: 76 · 2025: 89 · 2024: 95 · 2023: 76 · 2022: 81 · 2021: 81 · 2020: 69 · 2019: 47 · 2018: 47 · 2017: 46 · 2016: 42 · 2015: 40 · 2014: 45 · 2013: 37 · 2012: 20
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA120825, CA120825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial cancer therapy, synthetic biology, Salmonella, Clostridium, tumor targeting, bacterial cytotoxicity, bacterial stability, bacterial toxicity, tumor growth control, cancer immunotherapy
- MeSH terms
- Animals, Antineoplastic Agents, Clostridium, Genetic Engineering, Humans, Neoplasms, Salmonella
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.